Complications from Transvaginal Placement of Surgical Mesh Patches Still Being Reported to FDA
More than three years after the recall of several surgical mesh patches the FDA is still receiving reports of complications associated with the transvaginal placement of surgical mesh from nine different mesh patch manufacturers. Additional mesh products were added to the recall in 2007.
Transvaginal placement of surgical mesh is a procedure used in both hernia repair and pelvic organ prolapse (POP,) in which an organ, such as the bladder, bowel, rectum or uterus drops from its natural position and puts pressure against the vaginal wall.
The FDA Public Health Notification states, “Hundreds of thousands of hernia repair operations are performed each year both with and without surgical mesh, and patients generally recover quickly and do well after surgery.” It doesn’t comment about the relative number or safety of POP surgeries.
Despite the relative safety of this surgical procedure, for those patients who develop complications, the outcomes can have a seriously detrimental impact on their lives. Complications can include erosion through the vagina, infection, pain, incontinence and other urinary problem and recurrence of the prolapse. Other complications can include pain due to vaginal scarring, painful intercourse, and injury to adjacent tissues including blood vessels, bladder, and bowels.
If you have experienced any of these complications after surgical placement of a mesh patch you may be entitled to compensation. For more information on your rights as a consumer, and for a free, no-obligation consultation, please contact Schlichter, Bogard & Denton, the experienced consumer product and medical device attorneys.